Sorry you missed eyeforpharma Barcelona 2013...
The conference was held on 19-21 March and was a huge success, thank you to all those involved. Over 850 people attended, including more than 100 speakers from the pharma industry discussing how to prioritise your customer needs. The recordings and presentations can be found here.
We will be hosting the event again in March 2014 in Barcelona, so we hope to see you there. Sign up here to find out more about the hot topics that will be covered in the 12th edition.
Put the all-powerful customer at the centre: Revise pharma mindsets, models and structures to seal commercial success
eyeforpharma Barcelona 2013 is the leading pharma commercial event in the world- now in its 11th year, this three-day conference will tackle the most critical issues facing the Pharma and Med Device industry. Hear from 80+ senior level pharma speakers and network with an audience of over 1000 attendees from sales, marketing, digital, medical, commercial, market access - if you attend one event this year, make sure it's this one!
- NEW! The Keynote Customer Day: A passionate manifesto from doctors, payers and patients to spur you to deliver your portfolio around their future health vision
- Sell outcomes, not medicines: Align with your customer’s end goals to deliver real engagement ‘beyond the pill’
- Multichannel Masterclass: Personalise your approach by letting your customer select the right channel and right message. With case studies from Roche, BI, Novo, Pfizer and Novartis
- Internal collaboration: Get your product development and commercial teams working to deliver evidence, gain access and guarantee reimbursement
- Digital Reboot: Empower your digital sales reps with the right tools and the correct customer knowledge to sell more efficiently. Case studies from Santander
- Equip your team with the skillset and tools to thrive: Create best-in-class behaviour, establish skills benchmarks and cultivate digital expertise in your reps. Case studies from GSK, Medtronic and Grünenthal



































































